Coronavirus (SARS-CoV) Recruiting Phase 2 Trials for Sofosbuvir (DB08934)

Back to Coronavirus (SARS-CoV)

Also known as: Severe Acute Respiratory Syndrome / SARS-CoV Infection / SARS Virus / SARS / Sar / Severe acute respiratory syndrome (disorder) / Severe acute respiratory syndrome NOS

Indication	Status	Phase
DBCOND0038241 (Coronavirus (SARS-CoV))	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04561063	COVID-19 Prophylaxis South Africa (COVER HCW)	Prevention	Daclatasvir (DB09102) Nitazoxanide (DB00507) Sofosbuvir (DB08934)